| Date Filed | Type | Description |
| 03/07/2023 |
4
| Vounatsos Michel (Director) has filed a Form 4 on Zai Lab Ltd|
Txns:
| Granted 18,332 shares
@ $0 |
|
| 01/13/2023 |
3
| Vounatsos Michel (Director) has filed a Form 3 on Zai Lab Ltd |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Vounatsos Michel (CEO) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 2,746 shares
@ $209.79, valued at
$576.1k
Exercised 6,191 restricted stock units
@ $0
Disposed of 8,909 restricted stock units
@ $0 |
|
| 02/15/2022 |
4
| Vounatsos Michel (CEO) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 1,917 shares
@ $214.59, valued at
$411.4k
Paid exercise price by delivering 1,950 shares
@ $214.59, valued at
$418.5k
Paid exercise price by delivering 4,699 shares
@ $214.59, valued at
$1M
Exercised 4,321 restricted stock units
@ $0
Disposed of 8,205 restricted stock units
@ $0
Exercised 4,395 restricted stock units
@ $0
Disposed of 8,163 restricted stock units
@ $0 |
|
| 02/14/2022 |
4
| Vounatsos Michel (CEO) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 28,405 restricted stock units
@ $0 |
|
| 01/21/2022 |
4
| Vounatsos Michel (CEO) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 10,594 shares
@ $0 |
|
| 05/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Vounatsos Michel (CEO) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 16,343 shares
@ $0 |
|
| 12/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2019 |
4
| Vounatsos Michel (CEO) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 658 shares
@ $230.52, valued at
$151.7k
Exercised 1,480 restricted stock units
@ $0
Disposed of 1,772 restricted stock units
@ $0 |
|
| 05/02/2019 |
4
| Vounatsos Michel (CEO) has filed a Form 4 on BIOGEN INC.|
Txns:
| Bought 4,351 shares
@ $231.48, valued at
$1M
|
|
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2018 |
4
| Vounatsos Michel (CEO) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 750 shares
@ $274.13, valued at
$205.6k
Exercised 1,687 restricted stock units
@ $0
Disposed of 1,557 restricted stock units
@ $0 |
|
| 02/20/2018 |
4
| Vounatsos Michel (CEO) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 1,877 shares
@ $299.38, valued at
$561.9k
Exercised 5,354 restricted stock units
@ $0
Disposed of 3,144 restricted stock units
@ $0 |
|
| 02/14/2018 |
4
| Vounatsos Michel (CEO) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 36,320 restricted stock units
@ $0 |
|
| 01/02/2018 |
4
| Vounatsos Michel (CEO) has filed a Form 4 on BIOGEN INC.|
Txns:
| Bought 780 shares
@ $320.55, valued at
$250k
|
|
| 05/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/04/2016 |
4
| Vounatsos Michel (EVP & Chief Commercial Officer) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 9,520 restricted stock units
@ $0 |
|
| 04/22/2016 |
3
| Vounatsos Michel (EVP & Chief Commercial Officer) has filed a Form 3 on BIOGEN INC. |